Breast AI
Embrace the power of more
With our mammography systems and our multimodal visualization solutions for breast health, we combine the power of our market-unique 50° Wide-Angle Tomosynthesis, our Insight BD together with AI based decision support1.
We aim to let you see more, detect breast cancer earlier, and help women stay healthy.
Available in product Mammomat Inspiration, Mammomat Revelation, Mammovista Bsmart
50° Wide-Angle Tomosynthesis
Tomosynthesis is on the rise. Its use in screening is also being discussed more and more frequently - and for good reason. 15-30% of all breast cancers are not detected via standard mammography because of overlapping tissue.
With our unique 50° Wide-Angle Tomosynthesis we enable:
- the highest depth resolution
- the highest mass detectability at the right dose
- and a minimum of compression.
Insight BD
Insight Breast Density: Leverage quick and precise risk assessment
Objective classification supporting you in instant risk stratification right at the acquisition workstation, directly after the first scan for more predictable workflows and personalized breast care.
MAMMOVISTA B.smart
MAMMOVISTA B.smart covers the full spectrum of multimodal diagnostics from mammography to MRI and ultrasound. As an agile, vendor-neutral solution, it delivers exceptional performance for radiologists faced with more time-consuming tomosynthesis reading. Fully integrated next-gen AI support2 as well as side-by-side analysis of the related MR data is available in one view.
Customer experiences
Thanks to the 50-degree angle tomosynthesis of the Mammomat Revelation small distortions in the breast are easily detected. Also, benign or malignant characteristics of lesions are better depicted.
This technique helps us in daily practice to perform mammograms with more confidence and detect breast cancer in an earlier stage.
See the other topics here
Avez-vous jugé cette information utile?
1. Next-Gen AI is an option and available with Transpara® powered by FusionAITM ScreenPointMedical.
2. This feature is an option and available with MAMMOVISTA B.smart. Transpara® Powered by FusionAI, ScreenPoint Medical.
3. Lauritzen AD, Rodríguez-Ruiz A, von Euler-Chelpin MC, Lynge E, Vejborg I, Nielsen M, Karssemeijer N, Lillholm M.
An Artificial Intelligence-based Mammography Screening Protocol for Breast Cancer: Outcome and Radiologist Workload. Radiology. 2022 Apr 19:2109485. Siemens Healthineers reserves the right to modify the design and specifications contained herein without prior notice.